Cargando…
Targeting the proteostasis network in Huntington’s disease
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion mutation in the huntingtin protein. Expansions above 40 polyglutamine repeats are invariably fatal, following a symptomatic period characterised by choreiform movements, behavioural abno...
Autores principales: | Soares, Tânia R., Reis, Sara D., Pinho, Brígida R., Duchen, Michael R., Oliveira, Jorge M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320389/ https://www.ncbi.nlm.nih.gov/pubmed/30502498 http://dx.doi.org/10.1016/j.arr.2018.11.006 |
Ejemplares similares
-
The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice
por: Pinho, Brígida R., et al.
Publicado: (2020) -
Proteostasis in striatal cells and selective neurodegeneration in Huntington’s disease
por: Margulis, Julia, et al.
Publicado: (2014) -
Targeting the Proteostasis Network for Mycobacterial Drug Discovery
por: Lupoli, Tania J., et al.
Publicado: (2018) -
Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells
por: Pinho, Brígida R., et al.
Publicado: (2019) -
Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington’s Disease
por: Merino, Marián, et al.
Publicado: (2022)